Literature DB >> 2165768

Serotyping of human rotaviruses in Argentina by ELISA with monoclonal antibodies.

J Gómez1, M K Estes, D O Matson, R Bellinzoni, A Alvarez, S Grinstein.   

Abstract

Human rotaviruses are the major, recognized cause of infantile diarrhea worldwide. Characterization of naturally occurring human isolates indicates that there are six human rotavirus serotypes, four of which (serotype 1 to 4) are widespread. We utilized monoclonal antibodies specific for the VP of serotypes 1, 2, 3, and 4 as capture antibody in a sandwich enzyme-linked immunosorbent to serotype rotaviruses directly in stool samples. The stool samples were collected from 1983 through 1986, from two epidemiologic studies in the area of Buenos Aires, Argentina. All four serotypes assayed were found Serotype 2 and 3 viruses, which were detected most frequently in 1983 and 1984, were virtually undetected in 1985 and 1986 (chi 2 = 23, P = less than 0.001 for this difference). No significant difference was noted among the three collection sites for serotype prevalence. These results indicate that the changing predominance of rotavirus serotype in a given region can involve multiple serotypes at the same time. Analysis of an outbreak of diarrhea in two neighboring families which occurred during a prospective study of community diarrhea documented inter- and intra-family spread of one serotype of virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165768     DOI: 10.1007/BF01323169

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  31 in total

1.  Incidence of rotavirus in beef herds in Argentina.

Authors:  R C Bellinzoni; N Mattion; J L La Torre; E A Scodeller
Journal:  Res Vet Sci       Date:  1987-03       Impact factor: 2.534

2.  Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7.

Authors:  K Taniguchi; T Urasawa; Y Morita; H B Greenberg; S Urasawa
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

3.  Variation in neutralization epitopes of human rotaviruses in relation to genomic RNA polymorphism.

Authors:  B S Coulson
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Serotype determination of human rotavirus isolates and antibody prevalence in pediatric population in Hokkaido, Japan.

Authors:  S Urasawa; T Urasawa; K Taniguchi; S Chiba
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

6.  Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment.

Authors:  H B Greenberg; R G Wyatt; A Z Kapikian; A R Kalica; J Flores; R Jones
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  Enzyme-linked immunosorbent assays based on polyclonal and monoclonal antibodies for rotavirus detection.

Authors:  G M Beards; A D Campbell; N R Cottrell; J S Peiris; N Rees; R C Sanders; J A Shirley; H C Wood; T H Flewett
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

8.  Rapid serotyping of human rotavirus strains by solid-phase immune electron microscopy.

Authors:  G Gerna; N Passarani; M Battaglía; E Percivalle
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

9.  Epidemiology of rotavirus infection and gastroenteritis in prospectively monitored Argentine families with young children.

Authors:  S Grinstein; J A Gómez; J A Bercovich; E L Biscotti
Journal:  Am J Epidemiol       Date:  1989-08       Impact factor: 4.897

10.  Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants.

Authors:  J Flores; I Perez-Schael; M Gonzalez; D Garcia; M Perez; N Daoud; W Cunto; R M Chanock; A Z Kapikian
Journal:  Lancet       Date:  1987-04-18       Impact factor: 79.321

View more
  8 in total

1.  Emergence of G9 P[6] human rotaviruses in Argentina: phylogenetic relationships among G9 strains.

Authors:  K Bok; G Palacios; K Sijvarger; D Matson; J Gomez
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Distribution of serotypes of human rotavirus in different populations.

Authors:  P A Woods; J Gentsch; V Gouvea; L Mata; M Santosham; Z S Bai; S Urasawa; R I Glass
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Molecular epidemiology of group A rotavirus diarrhea among children in Buenos Aires, Argentina, from 1999 to 2003 and emergence of the infrequent genotype G12.

Authors:  A A Castello; M H Argüelles; R P Rota; A Olthoff; B Jiang; R I Glass; J R Gentsch; G Glikmann
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Prevalence of G and P serotypes among equine rotaviruses in the faeces of diarrhoeic foals.

Authors:  G F Browning; A P Begg
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  VP7 and VP4 genotyping of human group A rotavirus in Buenos Aires, Argentina.

Authors:  M H Argüelles; G A Villegas; A Castello; A Abrami; P D Ghiringhelli; L Semorile; G Glikmann
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  A rearranged genomic segment 11 is common to different human rotaviruses.

Authors:  S Giambiagi; I González Rodríguez; J Gómez; O Burrone
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

7.  Epidemiology of symptomatic human rotaviruses in Bangalore and Mysore, India, from 1988 to 1994 as determined by electropherotype, subgroup and serotype analysis.

Authors:  S Aijaz; K Gowda; H V Jagannath; R R Reddy; P P Maiya; R L Ward; H B Greenberg; M Raju; A Babu; C D Rao
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Group A rotavirus G type prevalence in two regions of Hungary.

Authors:  G Szücs; D O Matson; M Uj; E Kukán; I Mihály; Z Jelenik; M K Estes
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.